Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Tae Min Kim, Nicolas Girard, Grace Kah Mun Low, Jianmin Zhuo, Dae Young Yu, Yishen Yang, Maiko Murota, Cindy Thiow Koon Lim, Nora J. Kleinman & Byoung Chul Cho. (2023) Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy. Acta Oncologica 62:12, pages 1689-1697.
Read now
Read now
Dan Zhang, Li-li Han, Fen Du, Xiao-meng Liu, Jin Li, Hui-hui Wang, Ming-hui Song, Zeng Li & Guo-yin Li. (2019) FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC. OncoTargets and Therapy 12, pages 9809-9816.
Read now
Read now
Articles from other publishers (11)
Kien Hung Do, Duc Thanh Le, Tai Van Nguyen, Tu Anh Do & Chu Van Nguyen. (2023)
Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex
G719X
and
S768I
mutations: A case report from Vietnam and literature review
. Respirology Case Reports 11:5.
Crossref
Crossref
Batra Ullas, Nathany Shrinidhi, Sharma Mansi, Satya Narayan, Jain Parveen, Dhanda Surender, Jose T. Joslia & Mehta Anurag. (2022) All EGFR mutations are (not) created equal: focus on uncommon EGFR mutations. Journal of Cancer Research and Clinical Oncology 149:4, pages 1541-1549.
Crossref
Crossref
Konstantin K. Laktionov, Elena V. Artamonova, Tatiana N. Borisova, Valeriy V. Breder, Iurii M. Bychkov, Liubov Iu. Vladimirova, Nikita M. Volkov, Stepan M. Ergnian, Albina S. Zhabina, Pavel V. Kononets, Alexander E. Kuzminov, Evgeny V. Levchenko, Olga A. Malikhova, Dimitr T. Marinov, Sergey V. Miller, Fedor V. Moiseenko, Valeriia V. Mochal’nikova, Sergei N. Novikov, Oleg V. Pikin, Elena V. Reutova, Evgenii O. Rodionov, Dina D. Sakaeva, Ksenia A. Sarantseva, Anna I. Semenova, Aleksei V. Smolin, Vladimir M. Sotnikov, Sergei A. Tuzikov, Igor N. Turkin, Igor E. Tyurin, Vladimir D. Chkhikvadze, Konstantin I. Kolbanov, Marina V. Chernykh, Andrei V. Chernichenko, Aleksandr A. Fedenko, Elena V. Filonenko, Aleksei A. Nevol’skikh, Sergei A. Ivanov, Zhanna V. Khailova, Tigran G. Gevorkian, Aleksei V. Butenko, Ilmira R. Gil’mutdinova, Irina V. Gridneva, Mikhail A. Eremushkin, Margarita A. Zernova, Boris S. Kasparov, Denis V. Kovlen, Kristina O. Kondrat’eva, Tatiana V. Konchugova, Svetlana B. Korotkova, Anton A. Krutov, Olga A. Obukhova, Gennadii N. Ponomarenko, Tatiana Iu. Semiglazova, Aleksandra M. Stepanova & Marina M. Khulamkhanova. (2022) Malignant neoplasm of the bronchi and lung: Russian clinical guidelines. Journal of Modern Oncology 24:3, pages 269-304.
Crossref
Crossref
Lan‐Lan Pang, Jia‐Di Gan, Jia‐Rong Tan, Yi‐Hua Huang, Jun Liao, Wei‐Ting Liang, Peng‐Bo Deng & Wen‐Feng Fang. (2022)
Efficacy and potential resistance mechanisms of afatinib in advanced non–small cell lung cancer patients with
EGFR G719X
/
L861Q
/
S768I
. Cancer 128:21, pages 3804-3814.
Crossref
Crossref
Dylan E. O’Sullivan, Tamer N. Jarada, Amman Yusuf, Leo (Xun Yang) Hu, Priyanka Gogna, Darren R. Brenner, Erica Abbie, Jennifer B. Rose, Kiefer Eaton, Julia Elia-Pacitti, Emmanuel M. Ewara, Aliyah Pabani, Winson Y. Cheung & Devon J. Boyne. (2022) Prevalence, Treatment Patterns, and Outcomes of Individuals with EGFR Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion EGFR Mutation Carriers. Current Oncology 29:10, pages 7198-7208.
Crossref
Crossref
Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Parveen Jain, Surender Dhanda, Harkirat Singh, Arpit Jain & Anurag Mehta. (2022) EGFR detection by liquid biopsy: ripe for clinical usage. Future Oncology 18:1, pages 85-92.
Crossref
Crossref
Konstantin K. Laktionov, Elena V. Artamonova, Tatiana N. Borisova, Valerii V. Breder, Iurii M. Bychkov, Liubov Iu. Vladimirova, Nikita M. Volkov, Stepan M. Ergnian, Albina S. Zhabina, Pavel V. Kononets, Aleksandr E. Kuz’minov, Evgenii V. Levchenko, Olga A. Malikhova, Dimitr T. Marinov, Sergei V. Miller, Fedor V. Moiseenko, Valeriia V. Mochal’nikova, Sergei N. Novikov, Oleg V. Pikin, Elena V. Reutova, Evgenii O. Rodionov, Dina D. Sakaeva, Anna I. Semenova, Aleksei V. Smolin, Vladimir M. Sotnikov, Sergei A. Tuzikov, Igor N. Turkin, Igor E. Tiurin, Vladimir D. Chkhikvadze, Konstantin I. Kolbanov, Andrei V. Chernichenko, Aleksandr A. Fedenko, Elena V. Filonenko, Aleksei A. Nevol’skikh, Sergei A. Ivanov, Zhanna V. Khailova, Tigran G. Gevorkian, Aleksei V. Butenko, Ilmira R. Gil’mutdinova, Irina V. Gridneva, Mikhail A. Eremushkin, Margarita A. Zernova, Boris S. Kasparov, Denis V. Kovlen, Kristina O. Kondrat’eva, Tatiana V. Konchugova, Svetlana B. Korotkova, Anton A. Krutov, Olga A. Obukhova, Gennadii N. Ponomarenko, Tatiana Iu. Semiglazova, Aleksandra M. Stepanova, Galina A. Tkachenko & Marina M. Khulamkhanova. (2021) Malignant neoplasm of the bronchi and lung: Russian clinical guidelines. Journal of Modern Oncology 23:3, pages 369-402.
Crossref
Crossref
Félix Blanc-Durand, Marie Florescu, Mustapha Tehfe, Bertrand Routy, Raafat Alameddine, Danh Tran-Thanh & Normand Blais. (2021) Improvement of EGFR Testing over the Last Decade and Impact of Delaying TKI Initiation. Current Oncology 28:2, pages 1045-1055.
Crossref
Crossref
Matthew Z Guo, Kristen A Marrone, Alexander Spira, Kristine Freeman & Susan C Scott. (2021)
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for
EGFR
-mutated Non-small Cell Lung Cancer
. Oncology & Haematology 17:1, pages 42.
Crossref
Crossref
Varsha Singh, Aruna Nambirajan, Prabhat Singh Malik, Sanjay Thulkar, Ravindra Mohan Pandey, Kalpana Luthra, Sudheer Arava, Ruma Ray, Anant Mohan & Deepali Jain. (2020) Spectrum of uncommon and compound epidermal growth factor receptor mutations in non-small-cell lung carcinomas with treatment response and outcome analysis: A study from India. Lung Cancer 149, pages 53-60.
Crossref
Crossref
Yuri Taniguchi, Momoko Yamamoto, Hiroaki Ikushima, Sayaka Ohara, Hideyuki Takeshima, Toshio Sakatani & Kazuhiro Usui. (2019) Successful Treatment of Afatinib-Refractory Non-Small Cell Lung Cancer with Uncommon Complex EGFR Mutations Using Pembrolizumab: A Case Report. Case Reports in Oncology 12:2, pages 564-567.
Crossref
Crossref